Evaluating time to withdrawal of anti-Cancer drug indications that received FDA's accelerated approval.
Hayase HakariyaAkihhiko OzakiShai MulinariFrank MoriartyTetsuya TanimotoPublished in: QJM : monthly journal of the Association of Physicians (2024)